Dr. J. Donald Debethizy
Executive chairman
Pharmaceutical sciences
Noxxon Pharma
Germany
Biography
Dr. J. Donald deBethizy has had thirty years of experience in the biotechnology and consumer products industry. He has served as president and chief executive officer of Santaris Pharma A/S, Denmark and U.S., until September 2014, when the company was sold to Roche. He served as executive chairman of Contera Pharma ApS until it was sold to Bukwang Pharma in November 2014. Don was co-founder and chief executive officer of Targacept, Inc., U.S., a public biotechnology company listed on NASDAQ. He completed a postdoctoral fellowship at the Chemical Industry Institute of Toxicology at Research Triangle Park, NC. Dr. deBethizy has held adjunct appointments at Wake Forest University Babcock School of Management, Wake Forest University School of Medicine and Duke University. He also currently serves on the board of directors of Newron Pharmaceuticals SpA, arGEN-X N.V., Proterris Inc. and Rigontec GmbH and is chairman of Albumedix A/S.
Research Interest
Toxicology research.
